Published in Eur Neuropsychopharmacol on September 22, 2010
Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors. Behav Brain Res (2011) 1.29
50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov (2013) 1.28
The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol (2011) 1.25
Social defeat: impact on fear extinction and amygdala-prefrontal cortical theta synchrony in 5-HTT deficient mice. PLoS One (2011) 1.07
Fasting induces an anti-inflammatory effect on the neuroimmune system which a high-fat diet prevents. Obesity (Silver Spring) (2011) 1.01
Ontogeny and regulation of the serotonin transporter: providing insights into human disorders. Pharmacol Ther (2011) 0.96
Reduced sensitivity to both positive and negative reinforcement in mice over-expressing the 5-hydroxytryptamine transporter. Eur J Neurosci (2014) 0.86
Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice. Mol Autism (2013) 0.84
Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks. Neurosci Biobehav Rev (2014) 0.82
The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders. Front Pharmacol (2013) 0.80
d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption. Eur J Neurosci (2015) 0.79
Mapping functional brain activation using [14C]-iodoantipyrine in male serotonin transporter knockout mice. PLoS One (2011) 0.79
Effects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet (2014) 0.79
Transient postnatal fluoxetine decreases brain concentrations of 20-HETE and 15-epi-LXA4, arachidonic acid metabolites in adult mice. Prostaglandins Leukot Essent Fatty Acids (2015) 0.77
Transient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult mice. Prostaglandins Leukot Essent Fatty Acids (2014) 0.77
SERT and uncertainty: serotonin transporter expression influences information processing biases for ambiguous aversive cues in mice. Genes Brain Behav (2015) 0.77
Amygdala Lesions Reduce Anxiety-like Behavior in a Human Benzodiazepine-Sensitive Approach-Avoidance Conflict Test. Biol Psychiatry (2017) 0.77
Searching for cognitive enhancement in the Morris water maze: better and worse performance in D-amino acid oxidase knockout (Dao(-/-) ) mice. Eur J Neurosci (2016) 0.76
Amyloid β Enhances Typical Rodent Behavior While It Impairs Contextual Memory Consolidation. Behav Neurol (2015) 0.76
A mouse model to address unresolved antidepressant issues. Proc Natl Acad Sci U S A (2011) 0.76
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Serotonin transporter genetic variation and the response of the human amygdala. Science (2002) 9.31
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27
Regional dissociations within the hippocampus--memory and anxiety. Neurosci Biobehav Rev (2004) 4.44
A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry (2005) 4.33
Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci (2004) 3.56
Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci U S A (2002) 2.97
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol (1998) 2.94
Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem (1994) 2.77
A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry (2000) 2.50
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (2000) 2.32
Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry (2006) 2.31
Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology (1998) 2.26
Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc Natl Acad Sci U S A (2005) 2.24
The serotonin transporter promoter polymorphism is associated with cortisol response to psychosocial stress. Biol Psychiatry (2009) 2.21
Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet (1999) 2.16
Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res (2003) 2.12
Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behav Neurosci (2004) 2.09
Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology (2007) 1.60
Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behav Brain Res (2002) 1.58
A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry (2003) 1.58
Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Genet (2004) 1.57
Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav (2003) 1.54
Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B Neuropsychiatr Genet (2005) 1.50
Burrowing in rodents: a sensitive method for detecting behavioral dysfunction. Nat Protoc (2006) 1.39
Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology (2003) 1.36
Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci (2006) 1.32
Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br J Pharmacol (1991) 1.28
A sensitive open field measure of anxiolytic drug activity. Pharmacol Biochem Behav (1981) 1.23
Human 5-HT transporter availability predicts amygdala reactivity in vivo. J Neurosci (2007) 1.16
5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol (1995) 1.15
Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience (2006) 1.12
Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J Neurochem (1997) 1.11
Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet (2000) 1.08
Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med (2000) 1.07
5-HTTLPR moderates effects of current life events on neuroticism: differential susceptibility to environmental influences. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.02
The role of the serotonin transporter polymorphism for the endocrine stress response in newborns. Psychoneuroendocrinology (2009) 1.02
Serotonin manipulations and the structure of feeding behaviour. Appetite (1986) 1.01
Contribution of the functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults. Obesity (Silver Spring) (2008) 1.01
5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther (1995) 0.99
Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. Am J Med Genet (2001) 0.99
Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behav Neurosci (1993) 0.98
Current considerations in the treatment of generalized anxiety disorder. CNS Drugs (2009) 0.96
Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet (2000) 0.95
Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) (2007) 0.94
Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology (Berl) (1989) 0.93
Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesity. Int J Obes (Lond) (2010) 0.92
Alternative splicing of the human serotonin transporter gene. J Neurochem (1997) 0.91
Eating disorders, serotonin transporter polymorphisms and potential treatment response. Am J Pharmacogenomics (2004) 0.89
Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity. Psychiatry Res (2000) 0.88
Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. Drugs (1996) 0.84
Serotonin depletion in the dorsal and ventral hippocampus: effects on locomotor hyperactivity, prepulse inhibition and learning and memory. Neuropharmacology (2008) 0.83
Hypothalamic serotonin: pharmacological, biochemical, and behavioral analyses of its feeding-suppressive action. Clin Neuropharmacol (1988) 0.83
Mice overexpressing the 5-hydroxytryptamine transporter show no alterations in feeding behaviour and increased non-feeding responses to fenfluramine. Psychopharmacology (Berl) (2008) 0.82
Serotoninergic mechanisms in human feeding: the pharmacological evidence. Appetite (1986) 0.80
Serotonin transporter gene promoter polymorphism is associated with body mass index and obesity in non-elderly stroke patients. J Endocrinol Invest (2009) 0.79
Effects of diazepam and picrotoxin on hyponeophagia in rats. Neuropharmacology (1982) 0.79
Efficacy of fenfluramine and dexfenfluramine in the treatment of obesity: a meta-analysis. Methods Find Exp Clin Pharmacol (2000) 0.77
Relationships between hyponeophagia, diazepam sensitivity and benzodiazepine receptor binding in eighteen rat genotypes. Pharmacol Biochem Behav (1984) 0.76
Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice. Nat Genet (2004) 3.83
Separate neural pathways process different decision costs. Nat Neurosci (2006) 3.69
Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron (2007) 3.67
Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron (2012) 3.33
Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci (2004) 2.64
Functional organization of the medial frontal cortex. Curr Opin Neurobiol (2007) 2.50
Functional specialization within medial frontal cortex of the anterior cingulate for evaluating effort-related decisions. J Neurosci (2003) 2.20
A protocol for high-throughput phenotyping, suitable for quantitative trait analysis in mice. Mamm Genome (2006) 1.96
The role of rat medial frontal cortex in effort-based decision making. J Neurosci (2002) 1.91
Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry (2003) 1.79
Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks. Neuron (2008) 1.78
Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery. Behav Brain Res (2002) 1.73
Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur J Pharmacol (2009) 1.62
A within-subjects, within-task demonstration of intact spatial reference memory and impaired spatial working memory in glutamate receptor-A-deficient mice. J Neurosci (2003) 1.58
Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J Neurosci (2011) 1.56
A safe lithium mimetic for bipolar disorder. Nat Commun (2013) 1.51
A pathway-specific function for different AMPA receptor subunits in amygdala long-term potentiation and fear conditioning. J Neurosci (2007) 1.44
Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiol Aging (2010) 1.42
Anxiolytic effects of cytotoxic hippocampal lesions in rats. Behav Neurosci (2002) 1.36
Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci (2006) 1.32
Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model. Learn Mem (2009) 1.28
Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampus. Eur J Neurosci (2009) 1.24
Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci (2003) 1.23
Spatial working memory deficits in GluA1 AMPA receptor subunit knockout mice reflect impaired short-term habituation: evidence for Wagner's dual-process memory model. Neuropsychologia (2010) 1.22
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci U S A (2013) 1.17
Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies. Psychopharmacology (Berl) (2006) 1.17
Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol Dis (2007) 1.14
Comparing the role of the anterior cingulate cortex and 6-hydroxydopamine nucleus accumbens lesions on operant effort-based decision making. Eur J Neurosci (2009) 1.11
Calculating the cost of acting in frontal cortex. Ann N Y Acad Sci (2007) 1.11
The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after stroke. Behav Brain Res (2004) 1.09
The role of hippocampal glutamate receptor-A-dependent synaptic plasticity in conditional learning: the importance of spatiotemporal discontiguity. J Neurosci (2004) 1.09
Hemisphere-specific optogenetic stimulation reveals left-right asymmetry of hippocampal plasticity. Nat Neurosci (2011) 1.08
Brain tissue oxygen amperometry in behaving rats demonstrates functional dissociation of dorsal and ventral hippocampus during spatial processing and anxiety. Eur J Neurosci (2010) 1.06
Evaluating the links between schizophrenia and sleep and circadian rhythm disruption. J Neural Transm (Vienna) (2012) 1.05
Distinct contributions of frontal areas to emotion and social behaviour in the rat. Eur J Neurosci (2007) 1.04
Neurochemical identification of stereotypic burst-firing neurons in the rat dorsal raphe nucleus using juxtacellular labelling methods. Eur J Neurosci (2007) 1.00
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology (Berl) (2008) 1.00
Impaired outcome-specific devaluation of instrumental responding in mice with a targeted deletion of the AMPA receptor glutamate receptor 1 subunit. J Neurosci (2005) 1.00
Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport (2009) 0.99
Ablating adult neurogenesis in the rat has no effect on spatial processing: evidence from a novel pharmacogenetic model. PLoS Genet (2013) 0.99
In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptors. Neuropharmacology (2003) 0.98
The role of habituation in hippocampus-dependent spatial working memory tasks: evidence from GluA1 AMPA receptor subunit knockout mice. Hippocampus (2010) 0.98
Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci U S A (2007) 0.97
Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment. J Neurochem (2005) 0.97
Non-linear relationship between 5-HT transporter gene expression and frequency sensitivity of 5-HT signals. J Neurochem (2010) 0.97
Dorsal hippocampal N-methyl-D-aspartate receptors underlie spatial working memory performance during non-matching to place testing on the T-maze. Behav Brain Res (2007) 0.95
Fractionation of spatial memory in GRM2/3 (mGlu2/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition. Neuropsychopharmacology (2011) 0.94
Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis (2010) 0.94
Gap junctions between interneurons are required for normal spatial coding in the hippocampus and short-term spatial memory. J Neurosci (2011) 0.92
Deletion of the GluA1 AMPA receptor subunit impairs recency-dependent object recognition memory. Learn Mem (2011) 0.91
Hippocampal place cells can encode multiple trial-dependent features through rate remapping. J Neurosci (2012) 0.91
Characterisation of carbon paste electrodes for real-time amperometric monitoring of brain tissue oxygen. J Neurosci Methods (2010) 0.91
Amphetamine promotes task-dependent recovery following focal cortical ischaemic lesions in the rat. Behav Brain Res (2005) 0.90
Transgenic overexpression of the type I isoform of neuregulin 1 affects working memory and hippocampal oscillations but not long-term potentiation. Cereb Cortex (2011) 0.90
Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice. Am J Geriatr Psychiatry (2009) 0.90
Deletion of the GluA1 AMPA receptor subunit alters the expression of short-term memory. Learn Mem (2011) 0.89
A double dissociation between the effects of sub-pyrogenic systemic inflammation and hippocampal lesions on learning. Behav Brain Res (2009) 0.88
Regulation of markers of synaptic function in mouse models of depression: chronic mild stress and decreased expression of VGLUT1. J Neurochem (2010) 0.88
Deep brain stimulation of the nucleus accumbens shell increases impulsive behavior and tissue levels of dopamine and serotonin. Exp Neurol (2010) 0.88
Regulation of β-adrenergic control of heart rate by GTP-cyclohydrolase 1 (GCH1) and tetrahydrobiopterin. Cardiovasc Res (2012) 0.88
Competitive short-term and long-term memory processes in spatial habituation. J Exp Psychol Anim Behav Process (2011) 0.88
A role for midbrain raphe gamma aminobutyric acid neurons in 5-hydroxytryptamine feedback control. Neuroreport (2005) 0.88
Reduced sensitivity to both positive and negative reinforcement in mice over-expressing the 5-hydroxytryptamine transporter. Eur J Neurosci (2014) 0.86
Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus? Neuropharmacology (2011) 0.86
Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis. Neuropharmacology (2006) 0.86
Close temporal coupling of neuronal activity and tissue oxygen responses in rodent whisker barrel cortex. Eur J Neurosci (2011) 0.86
Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions. PLoS One (2013) 0.86
BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior. Nat Commun (2013) 0.85
Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies. Synapse (2003) 0.85
Hemodynamic responses in amygdala and hippocampus distinguish between aversive and neutral cues during Pavlovian fear conditioning in behaving rats. Eur J Neurosci (2012) 0.84
Brain responses to chronic social defeat stress: effects on regional oxidative metabolism as a function of a hedonic trait, and gene expression in susceptible and resilient rats. Eur Neuropsychopharmacol (2010) 0.84
Effect of acute tyrosine depletion in using a branched chain amino-acid mixture on dopamine neurotransmission in the rat brain. Neuropsychopharmacology (2006) 0.83
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole. J Pharmacol Exp Ther (2004) 0.83
Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B. Psychopharmacology (Berl) (2007) 0.83
Electrical stimulation of the dorsal and median raphe nuclei increases extracellular noradrenaline in rat hippocampus: Evidence for a 5-HT-independent mechanism. Pharmacol Biochem Behav (2002) 0.82
Systemic inflammation alters central 5-HT function as determined by pharmacological MRI. Neuroimage (2013) 0.82
Activation of 5-HT(6) receptors facilitates attentional set shifting. Psychopharmacology (Berl) (2009) 0.81
Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brain. Psychopharmacology (Berl) (2003) 0.81
Increased electrical and metabolic activity in the dorsal raphe nucleus of Parkinsonian rats. Brain Res (2008) 0.80
Differential gene expression in mutant mice overexpressing or deficient in the serotonin transporter: a focus on urocortin 1. Eur Neuropsychopharmacol (2010) 0.80
Effects of the 5-HT(4) receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levels. Neurosci Lett (2010) 0.80
High frequency stimulation of the subthalamic nucleus increases c-fos immunoreactivity in the dorsal raphe nucleus and afferent brain regions. J Psychiatr Res (2011) 0.79
Genetic variation in 5-hydroxytryptamine transporter expression causes adaptive changes in 5-HT₄ receptor levels. Int J Neuropsychopharmacol (2011) 0.79
d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption. Eur J Neurosci (2015) 0.79
A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission. Exp Neurol (2011) 0.79
Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain. Synapse (2007) 0.79
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization. J Pharmacol Exp Ther (2011) 0.79
Decreased striatal dopamine in group II metabotropic glutamate receptor (mGlu2/mGlu3) double knockout mice. BMC Neurosci (2013) 0.78
Parkinson's disease, DBS and suicide: a role for serotonin? Brain (2009) 0.78
Genetic mouse models relevant to schizophrenia: taking stock and looking forward. Neuropharmacology (2011) 0.78
Hippocampal lesions can enhance discrimination learning despite normal sensitivity to interference from incidental information. Hippocampus (2011) 0.77
Blockade of α2-adrenoceptors induces Arc gene expression in rat brain in a glutamate receptor-dependent manner: a combined qPCR, in situ hybridisation and immunocytochemistry study. Neuropharmacology (2012) 0.77